Medical Science News

RSS

Study reveals why patients with rare leukemia develop resistance to tagraxofusp

Researchers at The University of Texas MD Anderson Cancer Center have identified why some patients with a rare type of leukemia, called blastic plasmacytoid dendritic cell neoplasm (BPDCN), eventually develop resistance to tagraxofusp, the first Food and Drug Administration-approved treatment for this disease.

7 Jul 2026

Researchers identify key protein balancing gut immunity and inflammation

A protein produced by gut immune cells orchestrates both immune protection against pathogens and immune tolerance of gut bacteria, according to a study led by Weill Cornell Medicine investigators.

7 Jul 2026

Innovative polysaccharide hydrogels offer new hope for healing wounds

Announcing a new article publication in BIO Integration. Skin wound healing, especially in chronic non-healing conditions, such as diabetic foot ulcers and infected wounds, remains a formidable clinical challenge due to the complex pathophysiologic mechanisms and prolonged repair processes.

7 Jul 2026

Molecular changes in the liver of space travelers provide clues about aging

What happens to the human body in space may help scientists create new anti-aging therapies.

7 Jul 2026

Advanced 3D imaging reveals hidden nerve networks inside joints

Temporomandibular disorders (TMDs) are a group of more than 30 conditions that cause pain and dysfunction in the jaw.

7 Jul 2026

Researchers identify brain circuits responsible for triggering OCD symptoms

Most of the time, the origin of obsessive-compulsive disorder (OCD) is unknown, but in some rare cases, it starts after a brain injury, such as a stroke or a tumor.

7 Jul 2026

USC researcher wins NIH grant to study how the cochlea processes complex sounds

USC researcher Karolina Charaziak, PhD, has been awarded a $3.3 million National Institutes of Health (NIH) Research Project (R01) grant to study how the cochlea, the part of the inner ear responsible for hearing, processes complex sounds encountered in everyday life.

7 Jul 2026

Collaborative AI system helps accelerate clinical trial design

An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial design, one of the most difficult steps in drug development, according to a new study by Weill Cornell Medicine investigators.

7 Jul 2026

Adaptor proteins regulate macrophage behavior to control cancer growth

A new review was published in Volume 13 of Oncoscience on May 22, 2026, titled "Adaptor proteins regulating tumor-associated macrophage polarization during cancer progression."

7 Jul 2026

New drug candidate treats severe fatty liver disease by improving gut health

Researchers discovered that a potential drug developed at Michigan Medicine treats severe fatty liver disease by improving gut health, according to a study published in The Journal of Clinical Investigation.

7 Jul 2026

New nonhormonal therapy shows promise for treating Genitourinary Syndrome of Menopause

Researchers at the University of Colorado Anschutz have developed a promising nonhormonal therapy for women experiencing Genitourinary Syndrome of Menopause (GSM).

7 Jul 2026

Microbiome science merges with oncology for better cancer treatments

Cancer remains notoriously difficult to treat, partly because tumors co‑opt their surrounding environment, including the resident microbiota, to evade immune surveillance and resist conventional therapies.

7 Jul 2026

Study offers insight into how long-term inflammation may contribute to cognitive decline

The King's College London study, published in Nature Communications, offers insight into how long-term inflammation may contribute to cognitive decline in disorders such as Alzheimer's disease, aging, depression, and the lingering neurological effects of viral infections.

7 Jul 2026

Gut microbiome changes can signal future type 2 diabetes risk

The presence of certain bacteria in the gut microbiota, and fluctuations in a person's metabolism, can be seen in people who go on to develop type 2 diabetes years later.

7 Jul 2026

Eppendorf focuses outreach programs to advance STEM education in Europe

Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, today highlights its European outreach activities dedicated to addressing persistent challenges in STEM education.

From Eppendorf 7 Jul 2026

Beckman Coulter Diagnostics expands Alzheimer’s portfolio with CE-marked p-Tau217 blood test and new high-specificity research assay

Beckman Coulter Diagnostics, a global leader in clinical diagnostics and a Danaher company, today announced it received CE Mark under IVDR for its Access p-Tau217 assay, a blood test designed to support clinical evaluation of amyloid pathology in patients with signs and symptoms of cognitive decline.

7 Jul 2026

Frozen embryo transfers dominate assisted reproduction across Europe

More than 1.15 million assisted reproductive technology (ART) treatment cycles were reported across Europe in 2023, according to preliminary data presented by the European IVF Monitoring (EIM) Consortium at the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE).

6 Jul 2026